SP1-induced lncRNA DUBR promotes stemness and oxaliplatin resistance of hepatocellular carcinoma via E2F1-CIP2A feedback
Author:
Funder
National Natural Science Foundation of China
National Key Research and Development Program of China
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference70 articles.
1. Global cancer statistics;Torre;Ca - Cancer J. Clin.,2012
2. Hepatocellular carcinoma;Llovet;Nat. Rev. Dis. Prim.,2021
3. Phase II study of oxaliplatin in patients with unresectable, metastatic, or recurrent hepatocellular cancer: a California Cancer Consortium Trial;Yen;Am. J. Clin. Oncol.,2008
4. Hepatocellular carcinoma: clinical frontiers and perspectives;Bruix;Gut,2014
5. Maintenance of stemness in oxaliplatin-resistant hepatocellular carcinoma is associated with increased autocrine of IGF1;Bu;PLoS One,2014
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. HIF1A-AS2 promotes the metabolic reprogramming and progression of colorectal cancer via miR-141-3p/FOXC1 axis;Cell Death & Disease;2024-09-03
2. Advances in hepatocellular carcinoma drug resistance models;Frontiers in Medicine;2024-07-31
3. Current concepts of the crosstalk between lncRNA and E2F1: shedding light on the cancer therapy;Frontiers in Pharmacology;2024-07-25
4. Analysis of Carcinogenic Involvement of MicroRNA Pattern in Peripheral Non-Cancerous Tissues and Chronic Viral Liver Injury;International Journal of Molecular Sciences;2024-07-18
5. Relationship between lncRNA MALAT1 and Chemo-radiotherapy Resistance of Cancer Cells: Uncovered Truths;Cell Biochemistry and Biophysics;2024-05-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3